Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ligand signs global license agreement with Spectrum for Captisol-enabled melphalan

March 15, 2013

Isofol Medical completes first part of preclinical safety program for Modufolin

March 15, 2013

G-202 obtains FDA orphan drug designation

March 15, 2013

Oxford Gene Technology obtains license to prostate cancer biomarker

March 15, 2013

Pfizer prepares new BRD4 inhibitors

March 15, 2013

Researchers at Roche prepare new protein kinase inhibitors for cancer

March 14, 2013

Promising antitumor activity seen for NOV-C-ter in vitro and in vivo

March 14, 2013

Qurient gains exclusive worldwide rights to new kinase inhibitor for metastatic cancer

March 13, 2013

Merck KGaA divulges new FAK inhibitors

March 13, 2013

Tragara Pharmaceuticals presents pharmacokinetic data for TG-02 citrate

March 13, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...